Article ID Journal Published Year Pages File Type
5845772 Pulmonary Pharmacology & Therapeutics 2013 6 Pages PDF
Abstract

Asthma is increasingly recognized as a heterogeneous disease. However, identification of different subgroups or phenotypes has been complex and controversial. The convergence of both clinical and statistical approaches to grouping patients and their characteristics, in association with increasing recognition of molecular patterns is now beginning to move the field forward. Integration of efficacy data with targeted molecular therapies will eventually lead to more complete understanding of these “molecular phenotypes” and eventually lead to the identification of fully defined endoytpes. This process should improve our ability to treat more complex and severe forms of asthma.

Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
,